Search

Author/Creator Price, Tim

4. ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours. Issue 1 (December 2016)

Authors:
Segelov, Eva; Waring, Paul; Desai, Jayesh; Wilson, Kate; Gebski, Val; Thavaneswaran, Subotheni; Elez, Elena; Underhill, Craig; Pavlakis, Nick; Chantrill, Lorraine; Nott, Louise; Jefford, Michael; Khasraw, Mustafa; Day, Fiona; Wasan, Harpreet; Ciardiello, Fortunato; Karapetis, Chris; Joubert, Warr...
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. Issue 4 (2nd April 2020)

Authors:
Roy, Amitesh C.; Shapiro, Jeremy; Burge, Matt; Karapetis, Christos S.; Pavlakis, Nick; Segelov, Eva; Chau, Ian; Lordick, Florian; Chen, Li-Tong; Barbour, Andrew; Tebbutt, Niall; Price, Tim
Journal:
Expert review of anticancer therapy
Issue:
Volume 20:Issue 4(2020)
Page Start:
305
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Perceptions diverge on aspects related to substance use disorder: An analysis of individuals in recovery, physicians, nurses, and medical students. Issue 4 (2nd October 2021)

Authors:
Shreffler, Jacob; Shaw, Isaac; McGee, Suzanne; Bishop, Campbell; Thé, Selena; O'Brien, Daniel; Price, Tim; Huecker, Martin
Journal:
Substance abuse
Issue:
Volume 42:Issue 4(2021)
Page Start:
896
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗